Steven A. Kriegsman, Director at RXI PHARMACEUTICALS CORP (RXII), sold 1,100 shares at $4.59 ($5K) on 2009-06-23, disclosed to the SEC on 2009-06-25.
Scheduled sale ($5k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.59 | 500 | $2K | 44.9% |
| 2 | $4.69 | 600 | $3K | 55.1% |
| Total | $4.64 avg | 1,100 | $5K | 100% |
| Filing → |
| CYTR | BUY | 2012-02-24 | $51K | — | Filing → |
| RXII | SELL | 2009-08-20 | $28K | — | Filing → |
| RXII | SELL | 2009-07-06 | $13K | — | Filing → |